Leyden Laboratories Bv
Leyden Laboratories Bv
11/18/2024 | Press release | Archived content
PanFlu Wins BioTech Breakthrough Award For 2024 Monoclonal Antibody Solution Of The Year
Annual Awards Program Recognizes Innovation in the Global Life Sciences and Biotechnology Industries
PanFlu is the recipient of the "Monoclonal Antibody Solution of the Year" award in the fourth annual BioTech Breakthrough Awards program conducted by BioTech Breakthrough.
"Current seasonal flu vaccines don't always protect optimally, especially for the elderly and other vulnerable groups," said Koenraad Wiedhaup, a founder and CEO of Leyden Labs.
"Mucosal protection with PanFlu has the potential to provide people further control to protect themselves from seasonal flu," said Bryan Vaughn, Managing Director, BioTech Breakthrough.
Leyden Laboratories Bv published this content on November 18, 2024, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 28, 2026 at 19:25 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]